» Articles » PMID: 22321601

Machine Learning Amplifies the Effect of Parental Family History of Alzheimer's Disease on List Learning Strategy

Overview
Specialties Neurology
Psychology
Date 2012 Feb 11
PMID 22321601
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Identification of preclinical Alzheimer's disease (AD) is an essential first step in developing interventions to prevent or delay disease onset. In this study, we examine the hypothesis that deeper analyses of traditional cognitive tests may be useful in identifying subtle but potentially important learning and memory differences in asymptomatic populations that differ in risk for developing Alzheimer's disease. Subjects included 879 asymptomatic higher-risk persons (middle-aged children of parents with AD) and 355 asymptotic lower-risk persons (middle-aged children of parents without AD). All were administered the Rey Auditory Verbal Learning Test at baseline. Using machine learning approaches, we constructed a new measure that exploited finer differences in memory strategy than previous work focused on serial position and subjective organization. The new measure, based on stochastic gradient descent, provides a greater degree of statistical separation (p = 1.44 × 10-5) than previously observed for asymptomatic family history and non-family history groups, while controlling for apolipoprotein epsilon 4, age, gender, and education level. The results of our machine learning approach support analyzing memory strategy in detail to probe potential disease onset. Such distinct differences may be exploited in asymptomatic middle-aged persons as a potential risk factor for AD.

Citing Articles

Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors.

Talboom J, Haberg A, De Both M, Naymik M, Schrauwen I, Lewis C Elife. 2019; 8.

PMID: 31210642 PMC: 6615857. DOI: 10.7554/eLife.46179.


Advancing Alzheimer's research: A review of big data promises.

Zhang R, Simon G, Yu F Int J Med Inform. 2017; 106:48-56.

PMID: 28870383 PMC: 5590222. DOI: 10.1016/j.ijmedinf.2017.07.002.


Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Koscik R, La Rue A, Jonaitis E, Okonkwo O, Johnson S, Bendlin B Dement Geriatr Cogn Disord. 2014; 38(1-2):16-30.

PMID: 24556849 PMC: 4104157. DOI: 10.1159/000355682.


Cognitive activities and cognitive performance in middle-aged adults at risk for Alzheimer's disease.

Jonaitis E, La Rue A, Mueller K, Koscik R, Hermann B, Sager M Psychol Aging. 2013; 28(4):1004-14.

PMID: 24364404 PMC: 4029346. DOI: 10.1037/a0034838.

References
1.
Backman L, Jones S, Berger A, Jonsson Laukka E, Small B . Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology. 2005; 19(4):520-31. DOI: 10.1037/0894-4105.19.4.520. View

2.
Johnson S, Schmitz T, Trivedi M, Ries M, Torgerson B, Carlsson C . The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci. 2006; 26(22):6069-76. PMC: 2684824. DOI: 10.1523/JNEUROSCI.0959-06.2006. View

3.
Corder E, Caskey J . Early intervention in Alzheimer disease: The importance of APOE4 plus family history. Neurology. 2009; 73(24):2054-5. DOI: 10.1212/WNL.0b013e3181c67870. View

4.
Bousfield A, Bousfield W . Measurement of clustering and of sequential constancies in repeated free recall. Psychol Rep. 1966; 19(3):935-42. DOI: 10.2466/pr0.1966.19.3.935. View

5.
Barnes D, Yaffe K . The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011; 10(9):819-28. PMC: 3647614. DOI: 10.1016/S1474-4422(11)70072-2. View